Literature DB >> 25037081

Idiopathic inflammatory myopathies.

Mazen M Dimachkie1, Richard J Barohn2, Anthony A Amato3.   

Abstract

The idiopathic inflammatory myopathies (IIM) consist of rare heterogeneous autoimmune disorders that present with marked proximal and symmetric muscle weakness, except for distal and asymmetric weakness in inclusion body myositis. Despite many similarities, the IIM are fairly heterogeneous from the histopathologic and pathogenetic standpoints, and also show some clinical and treatment-response differences. The field has witnessed significant advances in our understanding of the pathophysiology and treatment of these rare disorders. This review focuses on dermatomyositis, polymyositis, and necrotizing myopathy, and examines current and promising therapies.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clinical presentation; Dermatomyositis; Diagnosis; Inclusion body myositis; Necrotizing myopathy; Pathology; Polymyositis; Treatment

Mesh:

Year:  2014        PMID: 25037081      PMCID: PMC4104537          DOI: 10.1016/j.ncl.2014.04.007

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  144 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

Review 2.  Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome.

Authors:  I Marie; S Josse; O Decaux; S Dominique; E Diot; C Landron; P Roblot; S Jouneau; P Y Hatron; K P Tiev; O Vittecoq; D Noel; L Mouthon; J-F Menard; F Jouen
Journal:  Autoimmun Rev       Date:  2012-02-03       Impact factor: 9.754

3.  Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study.

Authors:  B Sigurgeirsson; B Lindelöf; O Edhag; E Allander
Journal:  N Engl J Med       Date:  1992-02-06       Impact factor: 91.245

4.  Necrotizing myopathy: clinicoserologic associations.

Authors:  Elizabeth Ellis; Ju Ann Tan; Sue Lester; Graeme Tucker; Peter Blumbergs; Peter Roberts-Thomson; Vidya Limaye
Journal:  Muscle Nerve       Date:  2012-02       Impact factor: 3.217

5.  An unusual association: anti-Jo1 and anti-SRP antibodies in the serum of a patient with polymyositis.

Authors:  Melinda Vincze; Peter A Molnár; Judit Tumpek; Lászlóné Szollosi; Agnes Gyetvai; Anikó Kapitány; Katalin Dankó
Journal:  Clin Rheumatol       Date:  2010-03-12       Impact factor: 2.980

6.  Outcome of anti-PL12 positive patients with antisynthetase syndrome.

Authors:  Isabelle Marie; Séverine Josse; Olivier Decaux; Stéphane Dominique; Cédric Landron; Pascal Roblot; Stéphane Jouneau; Olivier Vittecoq; Fabienne Jouen
Journal:  Presse Med       Date:  2013-02-18       Impact factor: 1.228

Review 7.  The role of resistin in inflammatory myopathies.

Authors:  Mária Filková; Ladislav Senolt; Jiří Vencovský
Journal:  Curr Rheumatol Rep       Date:  2013-06       Impact factor: 4.592

8.  Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients.

Authors:  Agnès Sparsa; Eric Liozon; François Herrmann; Kim Ly; Valérie Lebrun; Pascale Soria; Véronique Loustaud-Ratti; Marie-Laure Bouyssou-Gauthier; Serge Boulinguez; Christophe Bédane; Marie-Odile Jauberteau; Elisabeth Vidal; Jean-Marie Bonnetblanc
Journal:  Arch Dermatol       Date:  2002-07

9.  Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.

Authors:  Nizar Chahin; Andrew G Engel
Journal:  Neurology       Date:  2007-09-19       Impact factor: 9.910

10.  Tocilizumab for the treatment of rheumatoid arthritis and other systemic autoimmune diseases: current perspectives and future directions.

Authors:  Atsushi Ogata; Toshio Tanaka
Journal:  Int J Rheumatol       Date:  2012-01-18
View more
  20 in total

Review 1.  Patient-Reported Outcomes in Adult Idiopathic Inflammatory Myopathies.

Authors:  Dana DiRenzo; Clifton O Bingham; Christopher A Mecoli
Journal:  Curr Rheumatol Rep       Date:  2019-11-19       Impact factor: 4.592

2.  [18F]Fluorodeoxyglucose positron emission tomography/computed tomography for diagnosing polymyositis/dermatomyositis.

Authors:  Lu Sun; Yuanfei Dong; Na Zhang; Xing Lv; Qiusong Chen; Wei Wei
Journal:  Exp Ther Med       Date:  2018-04-13       Impact factor: 2.447

Review 3.  Treatment of Juvenile Dermatomyositis: An Update.

Authors:  Charalampia Papadopoulou; Lucy R Wedderburn
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.022

4.  Profile of Pediatric Idiopathic Inflammatory Myopathies from a Tertiary Care Center of Eastern India.

Authors:  Sumantra Sarkar; Tanushree Mondal; Arpan Saha; Rakesh Mondal; Supratim Datta
Journal:  Indian J Pediatr       Date:  2017-03-02       Impact factor: 1.967

5.  [Advances in epigenetic markers of dermatomyositis/polymyositis].

Authors:  Y Y Yang; X X Zuo; H L Zhu; S J Liu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-04-18

6.  The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies.

Authors:  Shanshan Li; Yongpeng Ge; Hanbo Yang; Tao Wang; Xiaoxiao Zheng; Qinglin Peng; Xin Lu; Guochun Wang
Journal:  Clin Rheumatol       Date:  2019-03-12       Impact factor: 2.980

Review 7.  Corticosteroids in Myositis and Scleroderma.

Authors:  Anna Postolova; Jennifer K Chen; Lorinda Chung
Journal:  Rheum Dis Clin North Am       Date:  2015-10-26       Impact factor: 2.670

Review 8.  Renal Involvement in Idiopathic Inflammatory Myopathies.

Authors:  David Cucchiari; Claudio Angelini
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 9.  Autoimmune Myopathies: Updates on Evaluation and Treatment.

Authors:  Emer R McGrath; Christopher T Doughty; Anthony A Amato
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

10.  Calcium/Calmodulin-Dependent Protein Kinase IV (CaMKIV) Mediates Acute Skeletal Muscle Inflammatory Response.

Authors:  DanDan Shi; RuiCai Gu; YaFeng Song; MaoChao Ding; Tao Huang; MengXia Guo; JiangWei Xiao; WenHua Huang; Hua Liao
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.